BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37832030)

  • 1. The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
    Di Ciaccio PR; Polizzotto MN; Cwynarski K; Gerrie AS; Burton C; Bower M; Kuruvilla J; Montoto S; McKay P; Fox CP; Milliken S; Jiamsakul A; Osborne W; Collins GP; Manos K; Linton KM; Iyengar S; Kassam S; Limei MP; Kliman D; Wong Doo N; Watson AM; Fedele P; Yannakou CK; Hunt S; Ku M; Sehn LH; Smith A; Renshaw H; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Painter D; Thakrar N; Song KW; Hamad N
    Blood; 2024 Jan; 143(2):152-165. PubMed ID: 37832030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.
    Liu M; Liu B; Liu B; Wang Q; Ding L; Xia C; Dong L
    Oncol Rep; 2015 Apr; 33(4):1615-20. PubMed ID: 25695332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
    Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
    Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmablastic lymphoma: An update.
    Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient.
    Fukuo Y; Shibuya T; Ashizawa K; Ito K; Saeki M; Fukushima H; Takahashi M; Nomura K; Okahara K; Haga K; Akazawa Y; Nomura O; Ogura K; Okubo H; Nagahara A
    Intern Med; 2021 Sep; 60(18):2947-2952. PubMed ID: 33776007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature.
    Fu Z; Wang H; Lauwers GY; Jiang K; Jayaratne NL; Bridglal S; Dong N; Wang E; Chen L; Barclift DP; Zhang L
    Ann Diagn Pathol; 2023 Dec; 67():152204. PubMed ID: 37639839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review.
    Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Silva AMB; Pontes HAR; Lopes MA; de Almeida OP; Brennan PA; Fonseca FP
    J Oral Pathol Med; 2018 Nov; 47(10):915-922. PubMed ID: 29917262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
    Tchernonog E; Faurie P; Coppo P; Monjanel H; Bonnet A; Algarte Génin M; Mercier M; Dupuis J; Bijou F; Herbaux C; Delmer A; Fabiani B; Besson C; Le Gouill S; Gyan E; Laurent C; Ghesquieres H; Cartron G
    Ann Oncol; 2017 Apr; 28(4):843-848. PubMed ID: 28031174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmablastic lymphoma in HIV patients: Experience at a tertiary care hospital in eastern India.
    Bishnu S; Banerjee S; Bandyopadhyay D; Samui S; Bhattacharya S; Bose D
    Indian J Cancer; 2015; 52(4):563-7. PubMed ID: 26960478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse of Plasmablastic Lymphoma With Cutaneous Involvement in an Immunocompetent Male.
    Shwe S; Sharma AA; Lee BA; Smith JE
    Ear Nose Throat J; 2022 Jun; 101(5):NP222-NP225. PubMed ID: 32955361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmablastic lymphoma - single centre experience with infusional EPOCH chemotherapy.
    Jayachandran PK; Rajan AK; Karunakaran P; Mehra N; Selvarajan G; Kesana S; Dhanushkodi M; Radhakrishnan V; Sagar TG
    Leuk Res; 2020 Aug; 95():106391. PubMed ID: 32559556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
    Meer S; Perner Y; McAlpine ED; Willem P
    Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
    Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
    J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
    Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
    Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use.
    Vaughan J; Perner Y; Mayne E; Wiggill T
    HIV Med; 2021 Mar; 22(3):225-230. PubMed ID: 33022825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emerging Treatment Options of Plasmablastic Lymphoma: Analysis of 173 Individual Patient Outcomes.
    Makady NF; Ramzy D; Ghaly R; Abdel-Malek RR; Shohdy KS
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e255-e263. PubMed ID: 33419717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
    Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
    Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal plasmablastic lymphoma in Ebstein Barr virus positive and human immunodeficiency virus negative subject after external radiation therapy for prostatic cancer.
    Bricman L; Yengue P; Miscu C; Junius S; Waignein F; Vandenbulcke JM
    Acta Gastroenterol Belg; 2021; 84(4):663-665. PubMed ID: 34965049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmablastic lymphoma: Review of 60 Chinese cases and prognosis analysis.
    Han X; Duan M; Hu L; Zhou D; Zhang W
    Medicine (Baltimore); 2017 Mar; 96(9):e5981. PubMed ID: 28248855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.